Healthcare provider profile · identity verified

Gregory Joseph Robke, MD

Allopathic & Osteopathic Physicians|Internal Medicine · PLYMOUTH, MA · NPI 1003843202

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Gregory Joseph Robke, MD received $37.86 in general payments during 2025 across 2 reported records.

Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Wegovy.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 254 claims for Ozempic by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Rybelsus by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Wegovy as an associated drug or biological on 183056 records involving 75256 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Wegovy by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$37.86

2 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$37.86	100.0%	2	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$37.86	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Wegovy Normalized: wegovy	Drug	Novo Nordisk Inc	$20.17	1	2025
Source payment records 2025-07-21 · Novo Nordisk Inc · $20.17 · Open Payments source
Ozempic Normalized: ozempic	Drug	Novo Nordisk Inc	$17.69	1	2025
Source payment records 2025-04-01 · Novo Nordisk Inc · $17.69 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
Ozempic ozempic	2025	Ozempic	2024	254	exact normalized	Medicare Part D
Wegovy wegovy	2025	Wegovy	2024	11 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	254	45
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Rybelsus open payments reported associated product	CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076	Rybelsus · 2024 Exact normalized brand match · 1 Part D row	20	suppressed by CMS
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Wegovy open payments reported associated product	CMS Open Payments — General Payments 183056 supporting records · 75256 recipient NPIs · example record 1188130070	Wegovy · 2024 Exact normalized brand match · 1 Part D row	11	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1326	356
Lisinopril	Lisinopril	953	267
Levothyroxine Sodium	Levothyroxine Sodium	855	211
Amlodipine Besylate	Amlodipine Besylate	604	156
Simvastatin	Simvastatin	558	152
Omeprazole	Omeprazole	554	156
Hydrochlorothiazide	Hydrochlorothiazide	537	155
Metformin Hcl	Metformin Hcl	524	143
Metoprolol Succinate	Metoprolol Succinate	509	148
Losartan Potassium	Losartan Potassium	479	131
Pantoprazole Sodium	Pantoprazole Sodium	429	125
Prednisone	Prednisone	421	300
Tamsulosin Hcl	Tamsulosin Hcl	371	95
Trazodone Hcl	Trazodone Hcl	353	101
Oxycodone Hcl	Oxycodone Hcl	324	59
Gabapentin	Gabapentin	319	94
Alprazolam	Alprazolam	298	105
Allopurinol	Allopurinol	297	79
Rosuvastatin Calcium	Rosuvastatin Calcium	293	86
Furosemide	Furosemide	265	83
Ozempic	Semaglutide	254	45
Albuterol Sulfate Hfa	Albuterol Sulfate	252	87
Tramadol Hcl	Tramadol Hcl	243	88
Citalopram Hbr	Citalopram Hydrobromide	237	71
Eliquis	Apixaban	210	49
Propranolol Hcl Er	Propranolol Hcl	210	54
Lorazepam	Lorazepam	202	66
Meloxicam	Meloxicam	199	51
Spironolactone	Spironolactone	194	53
Sertraline Hcl	Sertraline Hcl	193	55
Clonazepam	Clonazepam	189	43
Zolpidem Tartrate	Zolpidem Tartrate	188	64
Atenolol	Atenolol	179	45
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	166	143
Glimepiride	Glimepiride	152	45
Pravastatin Sodium	Pravastatin Sodium	143	39
Doxazosin Mesylate	Doxazosin Mesylate	127	37
Fluticasone Propionate	Fluticasone Propionate	125	45
Ibuprofen	Ibuprofen	124	40
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	120	37
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	120	23
Buspirone Hcl	Buspirone Hcl	118	36
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	118	68
Duloxetine Hcl	Duloxetine Hcl	117	30
Metoprolol Tartrate	Metoprolol Tartrate	116	35
Azithromycin	Azithromycin	115	100
Alendronate Sodium	Alendronate Sodium	114	31
Valsartan	Valsartan	111	32
Amitriptyline Hcl	Amitriptyline Hcl	110	29
Escitalopram Oxalate	Escitalopram Oxalate	108	27
Fluoxetine Hcl	Fluoxetine Hcl	108	26
Morphine Sulfate Er	Morphine Sulfate	107	22
Ezetimibe	Ezetimibe	106	31
Breo Ellipta	Fluticasone/Vilanterol	105	24
Clopidogrel	Clopidogrel Bisulfate	103	26
Synthroid	Levothyroxine Sodium	100	27
Famotidine	Famotidine	99	30
Nortriptyline Hcl	Nortriptyline Hcl	98	31
Venlafaxine Hcl Er	Venlafaxine Hcl	98	28
Bupropion Xl	Bupropion Hcl	95	23
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	95	73
Celecoxib	Celecoxib	94	26
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	94	31
Amoxicillin	Amoxicillin	87	65
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	82	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	80	23
Metformin Hcl Er	Metformin Hcl	79	23
Finasteride	Finasteride	78	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	77	67
Mounjaro	Tirzepatide	77	11
Potassium Chloride	Potassium Chloride	77	22
Propranolol Hcl	Propranolol Hcl	76	25
Montelukast Sodium	Montelukast Sodium	75	26
Januvia	Sitagliptin Phosphate	71	19
Cephalexin	Cephalexin	68	60
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	68	37
Meclizine Hcl	Meclizine Hcl	68	27
Jardiance	Empagliflozin	67	15
Paroxetine Hcl	Paroxetine Hcl	67	18
Donepezil Hcl	Donepezil Hcl	66	16
Quetiapine Fumarate	Quetiapine Fumarate	65	14
Triamcinolone Acetonide	Triamcinolone Acetonide	65	43
Valacyclovir	Valacyclovir Hcl	65	21
Testosterone Cypionate	Testosterone Cypionate	64	12
Glipizide	Glipizide	63	17
Ondansetron Hcl	Ondansetron Hcl	63	24
Diazepam	Diazepam	62	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	62	16
Warfarin Sodium	Warfarin Sodium	62	18
Bupropion Hcl Sr	Bupropion Hcl	61	17
Xarelto	Rivaroxaban	61	16
Pregabalin	Pregabalin	60	22
Carvedilol	Carvedilol	59	16
Doxycycline Hyclate	Doxycycline Hyclate	55	43
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	53	44
Fluconazole	Fluconazole	52	34
Raloxifene Hcl	Raloxifene Hcl	52	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	50	13
Aripiprazole	Aripiprazole	47	11
Nystatin	Nystatin	45	22
Lovastatin	Lovastatin	44	11
Nabumetone	Nabumetone	43	24
Clonidine Hcl	Clonidine Hcl	42	12
Eszopiclone	Eszopiclone	40	suppressed
Verapamil Er	Verapamil Hcl	40	12
Terazosin Hcl	Terazosin Hcl	39	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Memantine Hcl	Memantine Hcl	38	suppressed
Estradiol	Estradiol	37	12
Acyclovir	Acyclovir	36	12
Cholestyramine	Cholestyramine (With Sugar)	36	17
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	36	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	36	13
Wixela Inhub	Fluticasone Propion/Salmeterol	36	suppressed
Fentanyl	Fentanyl	34	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	33	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	32	suppressed
Methadone Hcl	Methadone Hcl	32	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	32	suppressed
Oxycontin	Oxycodone Hcl	32	suppressed
Mirtazapine	Mirtazapine	31	11
Baclofen	Baclofen	30	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	15
Sildenafil Citrate	Sildenafil Citrate	28	suppressed
Temazepam	Temazepam	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	14
Zenpep	Lipase/Protease/Amylase	28	suppressed
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Mupirocin	Mupirocin	27	23
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Tiadylt Er	Diltiazem Hcl	27	13
Levetiracetam	Levetiracetam	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	11
Carisoprodol	Carisoprodol	25	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	25	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Incruse Ellipta	Umeclidinium Bromide	24	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Megestrol Acetate	Megestrol Acetate	24	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	24	24
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	13
Irbesartan	Irbesartan	22	suppressed
Labetalol Hcl	Labetalol Hcl	22	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Arnuity Ellipta	Fluticasone Furoate	21	suppressed
Felodipine Er	Felodipine	21	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	20	suppressed
Liothyronine Sodium	Liothyronine Sodium	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Rybelsus	Semaglutide	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Topiramate	Topiramate	19	suppressed
Torsemide	Torsemide	19	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Dilt-Xr	Diltiazem Hcl	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Eplerenone	Eplerenone	18	suppressed
Levofloxacin	Levofloxacin	18	14
Famciclovir	Famciclovir	17	12
Hydrocortisone	Hydrocortisone	17	11
Indapamide	Indapamide	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Oxazepam	Oxazepam	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Colchicine	Colchicine	16	suppressed
Dutasteride	Dutasteride	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Jantoven	Warfarin Sodium	16	suppressed
Levoxyl	Levothyroxine Sodium	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Azelastine Hcl	Azelastine Hcl	15	12
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	15	suppressed
Ibu	Ibuprofen	15	suppressed
Premarin	Estrogens, Conjugated	15	suppressed
Triazolam	Triazolam	15	suppressed
Digoxin	Digoxin	14	suppressed
Erythromycin	Erythromycin Base	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Metronidazole	Metronidazole	14	14
Phenobarbital	Phenobarbital	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Testosterone	Testosterone	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	14	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Yuvafem	Estradiol	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Glyburide	Glyburide	11	suppressed
Lactulose	Lactulose	11	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$37.86 · 2 records	Novo Nordisk Inc	Ozempic, Wegovy	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Ozempic play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error